0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

SOME CLINICAL USES OF PAPAVERINE IN HEART DISEASE

STEPHEN R. ELEK, M.D.; L. N. KATZ, M.D.
JAMA. 1942;120(6):434-441. doi:10.1001/jama.1942.02830410022006.
Text Size: A A A
Published online

Papaverine is an opium alkaloid of the benzylisoquinoline group, of low toxicity and non-habit forming.1 At the present time its widest clinical use is in the treatment of conditions associated with smooth muscle spasm, e. g. peripheral vascular embolism,2 pulmonary embolism,3 Raynaud's disease4 and ureteral5 or other types of tubular spasm.

We have recently investigated its action on the dog's heart and have found that it is a powerful and lasting coronary vasodilator,6 that it diminishes considerably the ease with which ventricular fibrillation is induced by faradic or other type of stimulation7 and that after its administration vigorous manual massage of the heart will restore orderly, synergic beating to the fibrillating ventricles.8

Further studies on the dog's heart9 revealed that: 1. Papaverine in large doses depresses auriculoventricular and intraventricular conductivity leading to auriculoventricular and intraventricular block. 2. It decreases or eliminates

Topics

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

79 Views
0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
×
brightcove.createExperiences();